[ad_1] Andrew Feldman, co-founder and CEO of Cerebras Systems, speaks at the Collision conference in Toronto…
Tag: AstraZeneca PLC
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
[ad_1] Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer…
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class…
A corner of the cancer therapy market is heating up—Here are the names investors need to know
[ad_1] There’s been a lot of attention lately on a corner of the oncology market called…
AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’
[ad_1] The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China,…
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
[ad_1] In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the…
Judge withdraws from Medicare drug price case after stock ownership is revealed
[ad_1] Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District…
These 10 medications are likely targets for Medicare price negotiations this fall
[ad_1] Merck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker…